Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
By J. Brooke. Clinical Microbiology Reviews, 2012
1,287 citations recorded by the source corpus.
Subfields: Endocrinology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/75d28ed5ca0cd98bcfe4dea747e1ec15a598e52f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Aminoglycosides: An Overview. (2016, background): “Aminoglycosides are also inactive against most Burkholderia spp. and Stenotrophomonas spp. as well as Streptococcus spp. and Enterococcus spp. (Brogden et al. 1976; Vakulenko and Mobashery 2003; Brooke 2012; Podnecky et al. 2015).”
- Treatment Strategies for Infected Wounds (2018, neutral): “Chronic wounds [47] Stenotrophomonas maltophilia [48,49] E.”
- Epidemiology of β-Lactamase-Producing Pathogens (2020, neutral): “creased mortality attributed to this organism (142).”